Overexpression of VEGF correlates with advanced tumor stage or tumor invasiveness in various types of human cancers and blockage of VEGF/VEGFR-2 signaling is a clinically proven strategy for the treatment of a number of cancers [18], [19]. The gene discussed is KDR; the disease is neoplasm.